Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.

Literature DB >> 11036046

A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.

C De Champs¹, D Sirot, C Chanal, R Bonnet, J Sirot.

Abstract

In a 3-month period in 1998, 79 consecutive isolates of Enterobacteriaceae producing an extended-spectrum beta-lactamase (ESBL) were collected. ESBLs were predominantly TEM derivatives (74 of 79): TEM-24-like (40 isolates), TEM-3-like (29 isolates), TEM-21 (3 isolates), and TEM-4 and TEM-52 (1 isolate each). Four isolates produced SHV derivatives SHV-4 (three isolates) and SHV-5 (one isolate), and one strain produced a CTX-M-3 enzyme. The high proportion of TEM-24-like-producing Enterobacter aerogenes isolates (36 of 79) suggests the occurrence of an epidemic strain in France.

Entities: Species

Mesh：

Substances：
beta-Lactamases

Year: 2000 PMID： 11036046 PMCID： PMC101626 DOI： 10.1128/AAC.44.11.3177-3179.2000

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

16 in total

Review 1. Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria.

Authors: J Heritage; F H M'Zali; D Gascoyne-Binzi; P M Hawkey
Journal: J Antimicrob Chemother Date: 1999-09 Impact factor: 5.790

2. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa.

Authors: P Nordmann; M Guibert
Journal: J Antimicrob Chemother Date: 1998-08 Impact factor: 5.790

3. Mechanisms of hyperproduction of TEM-1 beta-lactamase by clinical isolates of Escherichia coli.

Authors: P J Wu; K Shannon; I Phillips
Journal: J Antimicrob Chemother Date: 1995-12 Impact factor: 5.790

4. A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.

Authors: R Bonnet; J L Sampaio; R Labia; C De Champs; D Sirot; C Chanal; J Sirot
Journal: Antimicrob Agents Chemother Date: 2000-07 Impact factor: 5.191

5. Diversity of TEM mutants in Proteus mirabilis.

Authors: R Bonnet; C De Champs; D Sirot; C Chanal; R Labia; J Sirot
Journal: Antimicrob Agents Chemother Date: 1999-11 Impact factor: 5.191

6. Most Enterobacter aerogenes strains in France belong to a prevalent clone.

Authors: C Bosi; A Davin-Regli; C Bornet; M Mallea; J M Pages; C Bollet
Journal: J Clin Microbiol Date: 1999-07 Impact factor: 5.948

7. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998.

Authors: G S Babini; D M Livermore
Journal: J Antimicrob Chemother Date: 2000-02 Impact factor: 5.790

8. CDC definitions for nosocomial infections, 1988.

Authors: J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal: Am J Infect Control Date: 1988-06 Impact factor: 2.918

9. Survey of prevalence of extended spectrum beta-lactamases among enterobacteriaceae.

Authors: C Chanal; D Sirot; J P Romaszko; L Bret; J Sirot
Journal: J Antimicrob Chemother Date: 1996-07 Impact factor: 5.790

10. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam.

Authors: A Buré; P Legrand; G Arlet; V Jarlier; G Paul; A Philippon
Journal: Eur J Clin Microbiol Infect Dis Date: 1988-12 Impact factor: 3.267

42 in total

1. New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates.

Authors: C de Champs; C Monne; R Bonnet; W Sougakoff; D Sirot; C Chanal; J Sirot
Journal: Antimicrob Agents Chemother Date: 2001-04 Impact factor: 5.191

2. Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.

Authors: C Neuwirth; E Siebor; A Pechinot; J M Duez; M Pruneaux; F Garel; A Kazmierczak; R Labia
Journal: J Clin Microbiol Date: 2001-05 Impact factor: 5.948

3. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.

Authors: T Spanu; F Luzzaro; M Perilli; G Amicosante; A Toniolo; G Fadda
Journal: Antimicrob Agents Chemother Date: 2002-01 Impact factor: 5.191

4. Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina.

Authors: Alejandro Petroni; Alejandra Corso; Roberto Melano; María Luisa Cacace; Ana María Bru; Alicia Rossi; Marcelo Galas
Journal: Antimicrob Agents Chemother Date: 2002-05 Impact factor: 5.191

5. Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.

Authors: Mariagrazia Perilli; Emanuela Dell'Amico; Bernardetta Segatore; Maria Rosaria de Massis; Ciro Bianchi; Francesco Luzzaro; Gian Maria Rossolini; Antonio Toniolo; Giuseppe Nicoletti; Gianfranco Amicosante
Journal: J Clin Microbiol Date: 2002-02 Impact factor: 5.948

6. Clinical strain of Pseudomonas aeruginosa carrying a bla(TEM-21) gene located on a chromosomal interrupted TnA type transposon.

Authors: Véronique Dubois; Corinne Arpin; Patrick Noury; Claudine Quentin
Journal: Antimicrob Agents Chemother Date: 2002-11 Impact factor: 5.191

10. Extended-spectrum beta-lactamase TEM-24 in an Aeromonas clinical strain: acquisition from the prevalent Enterobacter aerogenes clone in France.

Authors: H Marchandin; S Godreuil; H Darbas; H Jean-Pierre; E Jumas-Bilak; C Chanal; R Bonnet
Journal: Antimicrob Agents Chemother Date: 2003-12 Impact factor: 5.191